172 related articles for article (PubMed ID: 15974811)
1. Distinguishing fibrovascular septa from vasculogenic mimicry patterns.
Lin AY; Maniotis AJ; Valyi-Nagy K; Majumdar D; Setty S; Kadkol S; Leach L; Pe'er J; Folberg R
Arch Pathol Lab Med; 2005 Jul; 129(7):884-92. PubMed ID: 15974811
[TBL] [Abstract][Full Text] [Related]
2. Tumor cell plasticity in uveal melanoma: microenvironment directed dampening of the invasive and metastatic genotype and phenotype accompanies the generation of vasculogenic mimicry patterns.
Folberg R; Arbieva Z; Moses J; Hayee A; Sandal T; Kadkol S; Lin AY; Valyi-Nagy K; Setty S; Leach L; Chévez-Barrios P; Larsen P; Majumdar D; Pe'er J; Maniotis AJ
Am J Pathol; 2006 Oct; 169(4):1376-89. PubMed ID: 17003493
[TBL] [Abstract][Full Text] [Related]
3. Density of PAS positive patterns in uveal melanoma: Correlation with vasculogenic mimicry, gene expression class, BAP-1 expression, macrophage infiltration, and risk for metastasis.
Stålhammar G; See TRO; Phillips SS; Grossniklaus HE
Mol Vis; 2019; 25():502-516. PubMed ID: 31588174
[TBL] [Abstract][Full Text] [Related]
4. Vasculogenic mimicry has no prognostic significance in pT3 and pT4 cutaneous melanoma.
Massi D; Franchi A; Paglierani M; Ketabchi S; Borgognoni L; Reali UM; Santucci M
Hum Pathol; 2004 Apr; 35(4):496-502. PubMed ID: 15116332
[TBL] [Abstract][Full Text] [Related]
5. Expression of type VI collagen in uveal melanoma: its role in pattern formation and tumor progression.
Daniels KJ; Boldt HC; Martin JA; Gardner LM; Meyer M; Folberg R
Lab Invest; 1996 Jul; 75(1):55-66. PubMed ID: 8683940
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin expression and serum levels in metastatic uveal melanoma: a pilot study.
Kadkol SS; Lin AY; Barak V; Kalickman I; Leach L; Valyi-Nagy K; Majumdar D; Setty S; Maniotis AJ; Folberg R; Pe'er J
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):802-6. PubMed ID: 16505010
[TBL] [Abstract][Full Text] [Related]
7. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry.
Maniotis AJ; Folberg R; Hess A; Seftor EA; Gardner LM; Pe'er J; Trent JM; Meltzer PS; Hendrix MJ
Am J Pathol; 1999 Sep; 155(3):739-52. PubMed ID: 10487832
[TBL] [Abstract][Full Text] [Related]
8. Uveal melanoma. Comparison of the prognostic value of fibrovascular loops, mean of the ten largest nucleoli, cell type, and tumor size.
McLean IW; Keefe KS; Burnier MN
Ophthalmology; 1997 May; 104(5):777-80. PubMed ID: 9160022
[TBL] [Abstract][Full Text] [Related]
9. Vasculogenic mimicry correlates to presenting symptoms and mortality in uveal melanoma.
Sabazade S; Gill V; Herrspiegel C; Stålhammar G
J Cancer Res Clin Oncol; 2022 Mar; 148(3):587-597. PubMed ID: 34775516
[TBL] [Abstract][Full Text] [Related]
10. Microcirculation patterns other than loops and networks in choroidal and ciliary body melanomas.
Folberg R; Chen X; Boldt HC; Pe'er J; Brown CK; Woolson RF; Maniotis AJ
Ophthalmology; 2001 May; 108(5):996-1001. PubMed ID: 11320035
[TBL] [Abstract][Full Text] [Related]
11. Comparison of microcirculation patterns and MIB-1 immunoreactivity in iris and posterior uveal melanoma.
Chowers I; Folberg R; Livni N; Pe'er J
Ophthalmology; 2001 Feb; 108(2):367-71. PubMed ID: 11158814
[TBL] [Abstract][Full Text] [Related]
12. The spatial distribution of monosomy 3 and network vasculogenic mimicry patterns in uveal melanoma.
Meir T; Zeschnigk M; Masshöfer L; Pe'er J; Chowers I
Invest Ophthalmol Vis Sci; 2007 May; 48(5):1918-22. PubMed ID: 17460242
[TBL] [Abstract][Full Text] [Related]
13. Biologic determinants of uveal melanoma metastatic phenotype: role of intermediate filaments as predictive markers.
Hendrix MJ; Seftor EA; Seftor RE; Gardner LM; Boldt HC; Meyer M; Pe'er J; Folberg R
Lab Invest; 1998 Feb; 78(2):153-63. PubMed ID: 9484713
[TBL] [Abstract][Full Text] [Related]
14. [Vasculogenic mimicry--potential target for tumor therapy].
Yue WY; Chen ZP
Ai Zheng; 2006 Jul; 25(7):914-6. PubMed ID: 16831290
[TBL] [Abstract][Full Text] [Related]
15. Association between microarray gene expression signature and extravascular matrix patterns in primary uveal melanomas.
Onken MD; Lin AY; Worley LA; Folberg R; Harbour JW
Am J Ophthalmol; 2005 Oct; 140(4):748-9. PubMed ID: 16226537
[TBL] [Abstract][Full Text] [Related]
16. Cooperative interactions of laminin 5 gamma2 chain, matrix metalloproteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma.
Seftor RE; Seftor EA; Koshikawa N; Meltzer PS; Gardner LM; Bilban M; Stetler-Stevenson WG; Quaranta V; Hendrix MJ
Cancer Res; 2001 Sep; 61(17):6322-7. PubMed ID: 11522618
[TBL] [Abstract][Full Text] [Related]
17. Expression of Antimicrobial Peptides by Uveal and Cutaneous Melanoma Cells and Investigation of Their Role in Tumor Cell Migration and Vasculogenic Mimicry.
Manarang JC; Otteson DC; McDermott AM
Curr Eye Res; 2017 Nov; 42(11):1474-1481. PubMed ID: 28910167
[TBL] [Abstract][Full Text] [Related]
18. Targeting the tumor microenvironment with chemically modified tetracyclines: inhibition of laminin 5 gamma2 chain promigratory fragments and vasculogenic mimicry.
Seftor RE; Seftor EA; Kirschmann DA; Hendrix MJ
Mol Cancer Ther; 2002 Nov; 1(13):1173-9. PubMed ID: 12479698
[TBL] [Abstract][Full Text] [Related]
19. Comparison of tumor-associated vasculatures in uveal and cutaneous melanomas.
Bhat P; Jakobiec FA; Folberg R
Semin Ophthalmol; 2009; 24(3):166-71. PubMed ID: 19437353
[TBL] [Abstract][Full Text] [Related]
20. Modeling the behavior of uveal melanoma in the liver.
Folberg R; Leach L; Valyi-Nagy K; Lin AY; Apushkin MA; Ai Z; Barak V; Majumdar D; Pe'er J; Maniotis AJ
Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):2967-74. PubMed ID: 17591861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
